Health
SARS-CoV-2 can disrupt the blood-brain barrier, find scientists – Drug Target Review
Binding of SARS-CoV-2 spike proteins to the brain’s endothelial cells could be the cause the neurological symptoms associated with COVID-19.
Posted: 2 November 2020 | Hannah Balfour (Drug Target Review) | No comments yet
Binding of SARS-CoV-2 spike proteins to the brains endothelial cells can cause the blood-brain barrier to become leaky, potentially causing the neurological symptoms associated with COVID-19.
While the causes of respiratory symptoms related to SARS-CoV-2 infection have been well studied, the vascular and neurological symptoms are more poorly understood.
In the case of respiratory symptoms, it is known that entry of the…
-
General10 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
General13 hours agoAlbanese beats drum on economy as trade clouds gather
-
Business10 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
Noosa News12 hours agoSurgeon partner of former premier to testify over his patient’s death